___

• 1. https://www.businesswire.com/news/home/20210426005303/en/Global-Antidepressants-Market-Report-2021-COVID-19-Causes-a-Surge-in-Demand-for-Antidepressant-Drugs-as-Mental-Health-Problems-Rise---ResearchAndMarkets.com
• 2. Oppong, E., Cato, A. C. (2015). Effects of glucocorticoids in the immune system. Glucocorticoid signaling 2015; 217-233
• 3. Cubała, W. J., Landowski, J., Dziadziuszko, M., Chrzanowska, A., Wielgomas, B. Magnesium, C-reactive protein, and cortisol in drug-naïve patients with short illness-duration, first episode major depressive disorder: possible immunomodulatory role for magnesium. Magnesium Research 2016; 24: 169-174
• 4. Demir, S., Atli, A., Bulut, M., İbiloğlu, A. O., Güneş, M., Kaya, M. C., Sır, A. Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy. Neuropsychiatric disease and treatment 2015; 11: 2253
• 5. Wei J, Zhang M, Zhou J. Myeloid-derived suppressor cells in major depression patients suppress T-cell responses through the production of reactive oxygen species. Psychiatry Res 2015; 228:695–701
• 6. Hannestad J, Dellagioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011; 36:2452–2459
• 7. Dahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Andreassen, O. A. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology 2014; 45:77-86
• 8. Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Vives, A. H., Cleare, A. J. Inflammation and clinical response to treatment in depression: a meta-analysis. European Neuropsychopharmacology 2015;25:1532-1543
• 9. Brunoni, A. R., Machado-Vieira, R., Sampaio-Junior, B., Vieira, E. L., Valiengo, L., Benseñor, I. M., Teixeira, A. L. Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: results from the SELECT-TDCS trial. Journal of affective disorders 2015;185:209-213
• 10. Szałach, Ł. P., Lisowska, K. A., Cubała, W. J. The influence of antidepressants on the immune system. Archivum immunologiae et therapiae experimentalis 2019; 67:143-151
• 11. Lagier, B., Lebel, B., Bousquet, J., Pene, J. Different modulation by histamine of IL‐4 and interferon‐gamma (IFN‐γ) release according to the phenotype of human Th0, Th1 and Th2 clones. Clinical & Experimental Immunology 1997;108:545-551
• 12. Vannier E, Miller LC, Dinarella CA. Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors. J Exp Med 1991; 174:281-284
• 13. Van der Pouw Kraan, T. C., Snijders, A., Boeije, L. C., de Groot, E. R., Alewijnse, A. E., Leurs, R., Aarden, L. A. Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. The Journal of clinical investigation 1998; 102:1866-1873
• 14. Elenkov, I. J., Webster, E., Papanicolaou, D. A., Fleisher, T. A., Chrousos, G. P., Wilder, R. L. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. The Journal of Immunology 1998:161(5):2586-2593
• 15. Parameswaran, N., and S. Patial. Tumor necrosis factor-α signaling in macrophages. Critical Reviews in Eukaryotic Gene Expression 2010; 20: 87–103
• 16. López-Abente, G., Mispireta, S.,Pollán, M. Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain. BMC cancer 2014;14(1): 1-10
• 17. Ince, M., A. Hausmann, M.V. Martínez-Díaz, D.M. Guldi, and T. Torres. Non-covalent versus covalent donor-acceptor systems based on near-infrared absorbing azulenocyanines and C60 fullerene derivatives. Chemical Communications 2012; 48:4058–4060
• 18. Ayaz F. Ruthenium pyridyl thiocyanate complex increased the production of pro-inflammatory TNFα and IL1β cytokines by the LPS stimulated mammalian macrophages in vitro. Molecular biology reports 2018; 45(6):2307-2312
• 19. Ayaz F., Yuzer A.. Immunostimulatory effect of Zinc Phthalocyanine derivatives on macrophages based on the pro-inflammatory TNFα and IL1β cytokine production levels M. Ince. Toxicol. In Vitro 2018; 53: 172–177
• 20. Önal, H. T., Yuzer, A., Ince, M., Ayaz, F. Photo induced anti-inflammatory activities of a Thiophene substituted subphthalocyanine derivative. Photodiagnosis and Photodynamic Therapy 2020; 30:101701
• 21. Gasparini, C., B.M. Foxwell, and M. Feldmann. RelB/p50 regulates TNF production in LPS-stimulated dendritic cells and macrophages. Cytokine 2013;61: 736–740
• 22. Jacobsen, P. L., Thorley, E. M., Curran, C. Real-world patient experience with sexual dysfunction and antidepressant use in patients with self-reported depression: A cross-sectional survey study. Neurology, Psychiatry and Brain Research 2020; 36:57-64
• 23. Landmann, R., Schaub, B., Link, S., Wacker, H.R. Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy. Biol. Psychiatry 1997;41: 675–681
• 24. Lee, K.M., Kim, Y.K. The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder. Int. Immunopharmacol 2006; 6:1298–1304
• 25. Müller, N., Hofschuster, E., Ackenheil, M., Mempel, W., & Eckstein, R. (1993). Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1993; 17: 713-730
• 26. Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015). Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain, behavior, and immunity 2015; 49: 206-215
• 27. Dowlati Y, Herrmann N, Swardfager W et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446-457
• 28. Hannestad J, Dellagioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011; 36: 2452-2459
• 29. Kubera, M., Curzytek, K., Majewska-Szczepanik, M., Szczepanik, M., Marcinska, K., Ptak, W., Leskiewicz, M., Maes, M., Basta-Kaim, A., Budziszewska, B., Detka, J.,Duda, W., Lason, W. Inhibitory effect of antidepressant drugs on contact hypersensitivity reaction. Pharmacol. Rep 2012; 64:714–722
• 30. Curzytek, K., Kubera, M., Szczepanik, M., Basta-Kaim, A., Leskiewicz, M., Budziszewska, B., Lason, W., Maes, M. Crosstalk between contact hypersensitivity reaction and antidepressant drugs. Pharmacol. Rep 2013; 65: 1673–1680
• 31. Lin, A., Song, C., Kenis, G., Bosmans, E., De Jongh, R., Scharpe, S., Maes, M. The in vitro immunosuppressive effects of moclobemide in healthy volunteers. J. Affect. Disord 2000; 58: 69–74
• 32. Xia, Z., DePierre, J.W., Nassberger, L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 1996; 34: 27–37